Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
Recruiting
Observational Study
Allogeneic Hematopoietic Stem Cell Recipients
Acute Respiratory Infection
Parainfluenza Virus (PIV)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 14 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Bronchiolitis obliterans (BO) is the well-known manifestation of the chronic pulmonary graft-versus-host disease(GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). The pathophysiology of BO is, however, poorly known. The available data strongly support the role of respiratory viruses, in particular paramyxoviruses (parainfluenzae virus (PIV), respiratory syncytial virus, metapn…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria :
* Adults having received a hematopoietic stem cell transplantation for less than two years
* Availability of respiratory function tests prior to infection
* Presence of PIV respiratory infection documented by identification of the virus by PCR in the upper and/or lower respirat…
Contacts